U.S. market Closed. Opens in 1 day 2 hours 49 minutes

PBLA | Panbela Therapeutics, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
RevenueN/AN/AN/AN/AN/A
Cost of Revenue25.65M35.73M10.01M5.75M4.32M
Gross Profit-25.65M-35.73M-10.01M-5.75M-4.32M
Operating Expenses25.65M34.09M10.01M5.75M4.32M
Selling, General & Admin5.03M6.04M4.59M3.25M1.97M
Research & Development20.61M28.05M5.42M2.50M2.35M
Other Operating ExpensesN/A-682.00K-602.00K605.00K-99.00K
Operating Income-51.29M-34.09M-10.01M-5.75M-4.32M
Other Expenses / Income25.84M-956.00K-613.00K691.00K-2.29M
Before Tax Income-25.45M-35.05M-10.62M-5.06M-6.62M
Income Tax Expenses-186.00K-116.00K-488.00K-295.00K-415.00K
Net Income-25.26M-34.93M-10.13M-4.77M-6.20M
Interest Expenses-317.00K288.00K11.00K17.00K2.19M
Basic Shares Outstanding108.00857.00487.00322.00237.00
Diluted Shares Outstanding108.00857.00487.00322.00237.00
EBITDA-51.29M-34.76M-10.61M-5.15M-4.42M
EBITDA Margin0.00%0.00%0.00%0.00%0.00%
EBIT-25.77M-34.76M-10.61M-5.05M-4.42M
EBIT Margin0.00%0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-312019-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙